A preliminary study to identify the likely risk for sarcopenia in older hospitalised patients with cardiovascular disease in Vietnam.
Vietnam
cardiovascular disease
frail older adults
patient care
sarcopenia
Journal
Australasian journal on ageing
ISSN: 1741-6612
Titre abrégé: Australas J Ageing
Pays: Australia
ID NLM: 9808874
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
05
11
2019
revised:
14
02
2020
accepted:
17
02
2020
pubmed:
10
4
2020
medline:
25
6
2021
entrez:
10
4
2020
Statut:
ppublish
Résumé
To investigate the prevalence of sarcopenia, its associated factors and its impact on readmission in older hospitalised patients with cardiovascular diseases (CVD) in Vietnam. Patients aged ≥60 with CVD were recruited from 12/2018 to 6/2019 at a tertiary hospital in Vietnam. Sarcopenia was defined by the criteria proposed by the Asian Working Group for Sarcopenia (AWGS). There were 251 participants, with a mean age of 73.7 ± 8.8, 39.4% were female, and 34.3% had sarcopenia. On multivariable logistic regression, heart failure, chronic kidney disease and being currently unmarried were significantly associated with sarcopenia. The incidence of 5-month readmission was 35.7% (50.0% in sarcopenic participants and 27.9% in non-sarcopenic participants, P = .001). Sarcopenia independently increased the risk of readmission (adjusted OR 2.19, 95% CI 1.08-4.42). Sarcopenia was present in one-third of older hospitalised patients with CVD and increased their risk of readmission. This finding suggests the need to raise awareness of sarcopenia among clinicians and older patients in Vietnam.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e315-e321Informations de copyright
© 2020 AJA Inc.
Références
Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol. 2013;168(2):934-945.
Sisto IR, Hauck M, Plentz RDM. Muscular atrophy in cardiovascular disease. Adv Exp Med Biol. 2018;1088:369-391.
Chen LK, Liu LK, Woo J et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95-101.
Cao L, Morley JE. Sarcopenia is recognized as an independent condition by an international classification of disease, Tenth Revision, Clinical Modification (ICD-10-CM) code. J Am Med Dir Assoc. 2016;17(8):675-677.
Morley JE. Sarcopenia in the elderly. Family Pract. 2012;29(Suppl 1):i44-i48.
Tanaka S, Kamiya K, Hamazaki N et al. Utility of SARC-F for assessing physical function in elderly patients with cardiovascular disease. J Am Med Dir Assoc. 2017;18(2):176-181.
Yu S, Appleton S, Chapman I et al. An anthropometric prediction equation for appendicular skeletal muscle mass in combination with a measure of muscle function to screen for sarcopenia in primary and aged care. J Am Med Dir Assoc. 2015;16(1):25-30.
Reijnierse EM, Buljan A, Tuttle CSL et al. Prevalence of sarcopenia in inpatients 70 years and older using different diagnostic criteria. Nurs Open. 2019;6(2):377-383.
Bianchi L, Abete P, Bellelli G et al. Prevalence and clinical correlates of sarcopenia, identified according to the EWGSOP definition and diagnostic algorithm, in hospitalized older people: the GLISTEN study. J Gerontol A Biol Sci Med Sci. 2017;72(11):1575-1581.
Cerri AP, Bellelli G, Mazzone A et al. Sarcopenia and malnutrition in acutely ill hospitalized elderly: prevalence and outcomes. Clin Nutr. 2015;34(4):745-751.
Gariballa S, Alessa A. Sarcopenia: prevalence and prognostic significance in hospitalized patients. Clin Nutr. 2013;32(5):772-776.
Yang M, Hu X, Wang H, Zhang L, Hao Q, Dong B. Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: a prospective study. J Cachexia Sarcopenia Muscle. 2017;8(2):251-258.
Zamboni M, Zoico E, Scartezzini T et al. Body composition changes in stable-weight elderly subjects: the effect of sex. Aging Clin Exp Res. 2003;15(4):321-327.
Anderson LJ, Liu H, Garcia JM. Sex differences in muscle wasting. Adv Exp Med Biol. 2017;1043:153-197.
Suzuki T, Palus S, Springer J. Skeletal muscle wasting in chronic heart failure. ESC Heart Fail. 2018;5(6):1099-1107.
Kentaro Kamiya NH, Matsuzawa R, Nozaki K. Sarcopenia: prevalence and prognostic implications in elderly patients with cardiovascular disease. J Cachexia Sarcopenia Muscle. 2017;2(2):1-13.
Bianchi L, Abete P, Bellelli G et al. Prevalence and clinical correlates of sarcopenia, identified according to the EWGSOP definition and diagnostic algorithm, in hospitalized older people: the GLISTEN study. J Gerontol A. 2017;72:20-30.
Collamati A, Marzetti E, Calvani R et al. Sarcopenia in heart failure: mechanisms and therapeutic strategies. J Geriatr Cardiol. 2016;13(7):615-624.
Yamada K, Kinugasa Y, Sota T et al. Inspiratory muscle weakness is associated with exercise intolerance in patients with heart failure with preserved ejection fraction: a preliminary study. J Card Fail. 2016;22(1):38-47.
Moorthi RN, Avin KG. Clinical relevance of sarcopenia in chronic kidney disease. Curr Opin Nephrol Hypertens. 2017;26(3):219-228.
Gollie JM, Harris-Love MO, Patel SS, Argani S. Chronic kidney disease: considerations for monitoring skeletal muscle health and prescribing resistance exercise. Clin Kidney J. 2018;11(6):822-831.
White TA, LeBrasseur NK. Myostatin and sarcopenia: opportunities and challenges - a mini-review. Gerontology. 2014;60(4):289-293.
Hsieh YM, Sung TS, Wan KS. A survey of nutrition and health status of solitary and non-solitary elders in Taiwan. J Nutr Health Aging. 2010;14(1):11-14.
Wysokinski A, Sobow T, Kloszewska I, Kostka T. Mechanisms of the anorexia of aging-a review. Age. 2015;37(4):9821.
Bauer J, Morley JE, Schols A et al. Sarcopenia: a time for action. An SCWD position paper. J Cachexia Sarcopenia Muscle. 2019;10(5):956-961.
Yoshimura Y, Bise T, Shimazu S et al. Effects of a leucine-enriched amino acid supplement on muscle mass, muscle strength, and physical function in post-stroke patients with sarcopenia: a randomized controlled trial. Nutrition. 2019;58:1-6.
Wittmann K, Sieber C, von Stengel S et al. Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study. Clin Interv Aging. 2016;11:1697-1706.
Park J, Kwon Y, Park H. Effects of 24-week aerobic and resistance training on carotid artery intima-media thickness and flow velocity in elderly women with sarcopenic obesity. J Atheroscler Thromb. 2017;24(11):1117-1124.
Ibrahim K, Howson FFA, Culliford DJ, Sayer AA, Roberts HC. The feasibility of assessing frailty and sarcopenia in hospitalised older people: a comparison of commonly used tools. BMC Geriatr. 2019;19(1):42.
Morley JE, Sanford AM. Editorial: Screening for sarcopenia. J Nutr Health Aging. 2019;23(9):768-770.